You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
弘和仁爱医疗(03869.HK)上半年业绩实现扭亏为盈至8202.9万元
格隆汇 08-28 21:24

格隆汇8月28日丨弘和仁爱医疗(03869.HK)发布中期业绩,截至2019年6月30日止6个月,公司实现收入2.09亿元人民币(下同),同比增长19.53%;毛利8444.3万元,同比增长56.82%;公司拥有人应占溢利8202.9万元,上年同期亏损3826.9万元;基本每股收益0.594元;不派中期股息。

2019年上半年,集团医院门诊量、住院量、手术量提升明显,比去年同期取得长足进步。上半年,集团的集团医院录得的门诊病人就诊人次约131.15万人次,同比增长25%。期内的住院病人就诊人次约4.55万人次,同比增长153%。期内的手术量约8641人次,同比增长233%。2018年以来,特别是2019年以来,集团强化集团医院综合运营管理已经取得较为显着的成效,为未来各集团医院健康稳定快速发展奠定了良好的基础。预计集团医院于2019年的门诊量、住院量及手术量会超过2018年的数据。

报告期内,公司收入增加了约19.5%,主要原因是从慈溪协和医院和浙江金华广福肿瘤医院收取的管理服务费增加及建德中医院有限公司向个体病人提供综合医院服务收入增加。期内,集团的综合医院服务收入由去年同期的8670万元增加至9830万元。期内收入增加主要是由于建德中医院向个体病人提供综合医院服务收入增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account